文献速递血管炎

85岁以上巨细胞动脉炎患者的特征与预后:病例对照研究

Features and prognosis of giant cell arteritis in patients over 85 years of age: A case-control study.
PubMed 文献 · Semin Arthritis Rheum · 2019-03-02

这项回顾性病例对照研究纳入法国两家大学医院1976/1998至2017年新诊断且随访≥6个月的865例巨细胞动脉炎(GCA)患者,其中87例≥85岁。结果显示≥85岁患者合并症更多、较少出现风湿性多肌痛、更易发生永久性视力丧失、复发更少、GCA恢复更少且治疗期间死亡更多;≥85岁是全队列1年死亡率升高的唯一相关因素。

要点

  • ≥85岁GCA患者永久性视力丧失风险更高,需警惕严重缺血并发症。
  • ≥85岁GCA患者治疗期间死亡风险更高,且1年死亡率升高仅与年龄≥85岁相关。
  • ≥85岁GCA患者较少出现风湿性多肌痛、复发更少且对糖皮质激素依赖更少。

核心结论

  • ≥85岁GCA患者以严重缺血并发症发生率更高和早期死亡风险增加为特征,需早期诊断和密切临床监测。

研究设计与样本

  • 回顾性病例对照研究,纳入法国两家大学医院1976或1998至2017年内科新诊断且随访至少6个月的GCA患者共865例,其中87例≥85岁。

主要发现

  • 与年轻患者相比,≥85岁患者合并症更多(OR=1.11-1.74,p<0.01)。
  • ≥85岁患者较少出现风湿性多肌痛(OR=0.33-0.96,p=0.04),更易发生永久性视力丧失(OR=1.29-3.81,p<0.01)。
  • ≥85岁患者对糖皮质激素依赖更少(OR=0.23-0.94,p=0.04),复发更少(OR=0.31-0.87,p=0.015),GCA恢复更少(OR=0.22-0.69,p<0.01),治疗期间死亡更多(OR=1.45-4.65,p=0.001)。
  • 年龄≥85岁是全队列1年死亡率升高的唯一相关因素(HR=1.77-5.81,p=0.0001)。

临床怎么用

  • 对≥85岁疑似GCA患者应尽早诊断,并密切监测严重缺血并发症和死亡风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We examined the initial features, course, and prognosis of giant cell arteritis (GCA) in patients ≥ 85 years of age (≥85 year) and compared them to those of younger patients. METHODS: The present retrospective study included all patients who were newly diagnosed with GCA in the Internal Departments of two French University Hospitals from 1976 or 1998 to 2017 and who were followed up for at least 6 months. Logistic regression analyses were conducted to identify baseline and prognostic characteristics associated with being ≥85 year. RESULTS: Of the 865 patients assessed in this study, 87 were ≥85 year. Compared to younger patients, patients ≥ 85 year had more comorbid conditions (odds ratio [OR] = 1.11-1.74, p < 0.01), less often exhibited polymyalgia rheumatica (PMR; OR = 0.33-0.96, p = 0.04), and more often developed permanent visual loss (OR = 1.29-3.81, p < 0.01). The older patients also showed less dependence on glucocorticoid (GC) medications (OR = 0.23-0.94, p = 0.04), had fewer relapses (OR = 0.31-0.87, p = 0.015), less often recovered from GCA (OR = 0.22-0.69, p < 0.01), and more often died during treatment (OR = 1.45-4.65, p = 0.001) compared to younger patients. Being ≥85 year was the only factor associated with an increased 1-year mortality (hazard ratio = 1.77-5.81, p = 0.0001) for the whole cohort. CONCLUSIONS: GCA in very elderly patients was characterized by a higher rate of severe ischemic complications and an increased risk for early death compared to younger patients. Thus, there is a need for the early diagnosis of GCA and close clinical monitoring in this unique population.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Liozon E, Delmas C, Dumonteil S, et al. Features and prognosis of giant cell arteritis in patients over 85 years of age: A case-control study. Semin Arthritis Rheum. 2019. PMID: 30910217. doi:10.1016/j.semarthrit.2019.02.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。